Latest Breaking News On - Prometheus labs inc - Page 4 : comparemela.com
Problems – And Solutions – For Securing Patent Protection Over Diagnostic Technologies | Fox Rothschild LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
3 Winning Strategies For Patenting Diagnostic Technologies
meddeviceonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meddeviceonline.com Daily Mail and Mail on Sunday newspapers.
In our previous post, we promised to revisit the
American Axle and
Ariosa petitions for certiorari in February 2021 once responses had been filed. However, the U.S. Supreme Court granted extensions in both cases; the first opposition has now come in from respondent Neapco in
American Axle, and the response of Illumina in the
Ariosa case is due later this month.
So here’s a quick recap of Neapco’s arguments. In short, Neapco argues that corner cases are inevitable in patent eligibility analysis under
Alice, and that fact doesn’t warrant the Supreme Court taking up such corner cases when they arise. Along the way, however, Neapco frames a completely different way of looking at the claims in question than American Axle presented in its petition, emphasizing the words “recite” or “refer” in various forms in a manner nearly synonymous with the contested phrase “directed to” that we have discussed before. Throughout this post, we’ll highlight such uses in bol
Trade Secret Litigation Boom Continues - Intellectual Property
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key .
Myriad Genetics, Inc.February 18, 2021 GMT
SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new technology and healthcare leaders who recently joined the company as well as key promotions to drive critical business functions, transformation and growth initiatives.
“With the addition of new leaders from other industry leading enterprises, we continue to augment our strong bench of talent across a range of functions that will accelerate the execution of our strategy with disciplined process management and proven expertise,” said Paul J. Diaz, president and CEO of Myriad Genetics. “We are pleased to welcome new teammates who share the passion for our mission to improve health and we